Polymorphisms associated with ion-channel disease
OwnerJohn Sotos, Mark Curran +2inventors
InventorsJohn Sotos, Mark Curran, Marco Guida, Hugh Rienhoff
Life of this patent
Estimating the term…
Loading patent…
OwnerJohn Sotos, Mark Curran +2inventors
InventorsJohn Sotos, Mark Curran, Marco Guida, Hugh Rienhoff
Estimating the term…
The present invention provides methods and materials to identify genetic abnormalities that predispose an individual to ion-channel diseases. The invention provides four polymorphic sites in the KCNQ1 gene that cause reduced conductance of the associated potassium ion channel current and a variant form of the KCNE1 gene which causes decreased conductance though the channel. The variant form of KCNE1 also acts synergistically with variants of KCNQ1 to cause further decreased conductance than either variant alone. The invention further provides polymorphisms in ion channel genes showing a higher frequency in populations afflicted with ion channel diseases or within control groups. The detection of these polymorphic sites that produce the potassium ion channel protein variants in either heterozygous or homozygous form in a subject indicates that the subject has, or is susceptible to, ion channel diseases such as congenital or acquired cardiac arrhythmia, LQT syndrome, SIDS, epilepsy, or hearing loss.
A method for genotyping an individual susceptible to or having an ion channel disease, comprising analyzing a nucleic acid sample from the individual for the presence of a mutation that results in asparagine at a position corresponding to position 393 of SEQ ID NO:1, or alanine at a position corresponding to position 408 of SEQ ID NO:1, wherein the ion channel disease is Sudden Infant Death Syndrome (SIDS).
Dependencies are inferred from the claim text.